GL1X · GenesisL1 explorer

Research workbench

Structural basis for a new mechanism of inhibition of HIV integrase identified by fragment screening and structure based design

Analyse Structural basis for a new mechanism of inhibition of HIV integrase identified… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3NF6
Type
protein
Length
298 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Integrase
UniProt
Q76353
Ligands
IMV, SO4, CL
Pockets
7 · best druggability 0.67

Structure

x-ray diffraction · 1 distinct chain · 53% helix, 21% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BIntegraseprotein14953% helix, 21% strandQ76353

Ligands and binding sites

  • IMV · 5-[(2-oxo-2,3-dihydro-1H-indol-1-yl)methyl]-1,3-benzodioxole-4-carboxylic acid · ligand · 4 copies · chains A, B
  • SO4 · Sulfate ion · ion · 4 copies · chains A, B
  • CL · Chloride ion · ion · 2 copies · chains A, B
  • EDO · 1,2-ethanediol · additive · 4 copies · chains A, B
  • ACY · Acetic acid · additive · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

7 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12410.670.8429ACY
21000.480.8123EDO
3950.470.8124EDO
41460.440.7528IMV
5980.400.7616IMV

Interfaces

1 interface between chains.

  • A–B · 1517 Ų buried · 21 hydrogen bonds · protein-protein

Compared structures

  • 3NF6 · Structural basis for a new mechanism of inhibition of HIV integrase identified by… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.